As a packaging card supplier who’s spent the last 12 years working directly with pharma manufacturers and contract packagers, I get asked this question at least once a week by new prospects and even some long-time clients: Can packaging cards—you know, the rigid, printed cardstock we usually use for blister card packaging, product inserts, or secondary cartons—actually be used for pharmaceutical products? Packaging Card
For years, the industry default has been to rely on plastic blisters, foil lidding, and rigid polymer cartons for drugs, vaccines, and over-the-counter (OTC) medications. I’ve sat through countless meetings where pharma quality teams dismiss card-based packaging out of hand, citing old assumptions that paper can’t meet the strict sterility, barrier, or regulatory standards required for life-saving products. But over the past five years, that’s shifted dramatically—and as someone who’s tested, modified, and supplied card packaging for more than 40 different pharma SKUs ranging from liquid antibiotics to pediatric chewable vitamins, I can tell you the answer is not just “yes”—it’s “yes, and in many cases, it’s better for both patients and manufacturers.”
Let’s start with the basics: What do pharma products actually need from their packaging? At its core, pharmaceutical packaging has three non-negotiable requirements: it must protect the product from environmental damage, maintain label integrity and regulatory compliance, and be tamper-evident. Beyond that, many manufacturers are now prioritizing supply chain resilience, patient access, and sustainability—something card-based packaging is uniquely positioned to deliver, as long as it’s engineered correctly.
The biggest knock on card packaging for pharma has always been barrier performance. For uninitiated, standard 14pt cardstock (the stuff you see on greeting cards or product boxes) absorbs moisture, lets oxygen seep through, and won’t block light—all of which can degrade sensitive drugs like insulin, biologic medications, or topical creams. But that’s not the card packaging you work with if you’re a pharma supplier. Over the last decade, we’ve developed and refined coated, laminated, and functionalized card substrates that meet the exact barrier standards pharma requires. For example, our pharma-grade barrier cards use a proprietary polymer lamination that creates a moisture, oxygen, and light barrier equivalent to PVC (the gold standard for blister packaging) but with a fraction of the environmental impact. Last year, we supplied these cards to a generic drug maker for their oral contraceptive packaging, and third-party testing from a leading pharma lab showed the card’s moisture vapor transmission rate (MVTR) was less than 0.5 g/m²/day—well below the USP (United States Pharmacopeia) <661> limit for moisture-sensitive products.
Another common misconception: Card packaging can’t be sterile. Again, that’s true for basic cardstock, but not for the medical-grade card substrates we manufacture for the pharma space. Our cards undergo a validated gamma irradiation process that reduces bioburden to less than 1 colony-forming unit (CFU) per 100 square centimeters, meeting the FDA’s sterile product requirements for both solid and liquid dose forms. We also offer ethylene oxide (EtO) sterilization for applications that require ultra-low heat processing, like packaging for temperature-sensitive vaccines. I’ve seen this firsthand with a pediatric vaccine manufacturer that switched from plastic vial cartons to our barrier cards; the sterilization process didn’t affect the card’s print quality or barrier properties, and the manufacturer reduced its packaging waste by 40% in the first year.
Then there’s tamper evidence—a critical requirement for pharma products. Card-based packaging can be engineered to be just as tamper-evident as plastic or foil, without the added cost or waste. We integrate a pressure-sensitive tamper band along the seal of blister cards, or a permanent breakaway seal on secondary cartons, so any attempt to open the package leaves visible, irreversible damage. For example, last quarter we supplied cards for a series of topical antibiotic ointment blister packs; the tamper-evident lidding on the card creates a “void if opened” mark across the entire seal, so even a tiny pry attempt is immediately visible to patients.
But beyond the technical specs, there are tangible benefits that make card packaging a smart choice for pharma, not just a viable one. First, sustainability. The pharma industry generates an estimated 2.5 million tons of packaging waste annually in the U.S. alone, and many manufacturers are facing pressure from both consumers and regulators to cut back on single-use plastics. Card packaging is 100% recyclable, compostable (when uncoated with non-toxic materials), and uses 75% less energy to manufacture than PVC or PET plastic packaging. Last year, a leading OTC drug brand switched to our pharma-grade barrier cards for their cold and flu tablets, and reported a 28% reduction in their packaging carbon footprint, along with a 15% increase in consumer trust—studies show 62% of shoppers prioritize brands with sustainable packaging, and card-based materials are seen as far more eco-friendly than plastic.
Supply chain resilience is another big one. Post-pandemic, plastic and foil supply chains have been notoriously unstable, with lead times extending up to 12 weeks for some materials. Card packaging, by contrast, is sourced from domestic pulp mills in North America and Europe, with lead times as low as 2 weeks for custom orders. I had a client last year that faced a 10-week delay in their plastic blister packaging, which threatened to halt production of their generic blood pressure medication. We switched them to our stock pharma-grade cards, modified their existing blister machine in 3 days, and got them back up and running in a week—saving them an estimated $2.2 million in lost revenue. That’s the kind of flexibility card packaging brings that plastic can’t match.
Of course, that’s not to say card packaging is a perfect fit for every pharmaceutical product. It’s not ideal for ultra-sensitive biologic drugs that require hermetic, long-term storage for years (though we’re currently working on a new foil-laminated card substrate that meets 5-year barrier requirements for those uses). It also requires compatible manufacturing equipment—most existing blister card machines can be adapted for card packaging in a matter of days, but for high-volume lines, you may need minor modifications. The key is working with a packaging card supplier who understands the unique needs of pharma, not just generic packaging.
Over the years, I’ve learned that the best pharma packaging is the one that works for the product, the manufacturer, and the patient. Card-based packaging has come a long way from the flimsy paper inserts of the 90s. Today’s pharma-grade cards meet all the regulatory standards, reduce environmental impact, and offer supply chain flexibility that plastic can’t. I’ve seen clients go from skeptical to full converts, and the feedback I get from patients is always the same: card packaging is easier to open, clearer to read, and just feels more trustworthy.
If you’re a pharma manufacturer, contract packager, or brand owner who’s curious about whether card packaging can work for your products, I’m here to help. I’ve worked with every type of pharma SKU, from oral tablets and topical creams to pediatric vaccines and OTC medications, and I can walk you through testing, regulatory compliance, and cost comparisons tailored to your specific needs. Let’s connect to discuss your packaging goals, ask any questions you have about card-based solutions, and explore if this versatile, sustainable option is right for your products.
Courier Box References
- United States Pharmacopeia. <661> Containers – Performance Requirements. Rockville, MD: United States Pharmacopeial Convention; 2023.
- Pharmaceutical Packaging Association. Sustainable Packaging Benchmark Report 2024. Arlington, VA: Pharmaceutical Packaging Association; 2024.
- International Organization for Standardization. ISO 11607:2019 Packaging for Terminally Sterilized Medical Devices. Geneva, Switzerland: International Organization for Standardization; 2019.
- Smith, L. et al. Barrier Performance of Laminated Card Substrates for Pharmaceutical Packaging. Journal of Pharmaceutical Packaging Science. 2022; 14(2): 112-127.
- FDA. Guidance for Industry: Packaging and Labeling for Human Drug Products. Silver Spring, MD: U.S. Food and Drug Administration; 2021.
Hangzhou Yitian Printed Goods Co., Ltd.
We’re well-known as one of the leading packaging card manufacturers and suppliers in China, also support customized service. Please feel free to buy high quality packaging card made in China here and get pricelist from our factory. For price consultation, contact us.
Address: Room 1719-1, Building 2, Xinglan Building, No. 2333 Xixing Road, Xixing Subdistrict, Binjiang District, Hangzhou City, Zhejiang Province
E-mail: sxyunchao2023@163.com
WebSite: https://www.ytcarton.com/
